Carlos H Nitta Selected Research

transcription factor NF-AT c3

5/2013	NFAT is required for spontaneous pulmonary hypertension in superoxide dismutase 1 knockout mice.
8/2011	Endothelin-1 contributes to increased NFATc3 activation by chronic hypoxia in pulmonary arteries.
8/2010	NFATc3 contributes to intermittent hypoxia-induced arterial remodeling in mice.
9/2009	Regulation of soluble guanylyl cyclase-alpha1 expression in chronic hypoxia-induced pulmonary hypertension: role of NFATc3 and HuR.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carlos H Nitta Research Topics

Disease

5	Hypoxia (Hypoxemia) 01/2014 - 09/2009
2	Vascular Remodeling 05/2013 - 08/2011
2	Pulmonary Hypertension 05/2013 - 09/2009
1	Cellulitis 01/2018
1	Soft Tissue Infections 01/2018
1	Abscess 01/2018
1	Hypertension (High Blood Pressure) 08/2010

Drug/Important Bio-Agent (IBA)

4	transcription factor NF-AT c3IBA 05/2013 - 09/2009
2	Protein Isoforms (Isoforms)IBA 08/2011 - 08/2010
1	ChlorhexidineIBA 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	Vasoconstrictor AgentsIBA 01/2014
1	Acid Sensing Ion ChannelsIBA 01/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2013
1	Superoxides (Superoxide)IBA 05/2013
1	Superoxide Dismutase-1IBA 05/2013
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 05/2013
1	Transcription Factors (Transcription Factor)IBA 08/2011
1	Endothelin-1 (Endothelin 1)IBA 08/2011
1	CalcineurinIBA 08/2010
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 08/2010
1	Actins (F Actin)IBA 09/2009
1	NFATC Transcription FactorsIBA 09/2009
1	Differentiation AntigensIBA 09/2009

Therapy/Procedure

1	Baths 01/2018
1	Injections 01/2018